Learn more about autos

Updated – 29 : 06 : 2006

YONKERS, NY December 9 2003–The United States Patent and Trademark Office (USPTO) has issued today Patent # 6,660,831 METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS. The patent, which will remain in force until 2017, covers the use of the neuropeptide secretin for the treatment of symptoms associated with familial dysautonomia. The patent was issued to Dr. Joan Fallon with offices in Yonkers, NY. Familal dysautonomia (FD) which is also known as Riley-day syndrome, is an autosomal recessive disease that affects approximately 1 in 4,000 individuals of Ashkenazi Jewish descent. This disorder is marked by a reduction of unmyelinated and small myelinated fibers as well as a reduction of dopamine-beta-hyrozylase in the blood.. Symptomotology of FD includes: renal disease, corneal ulcerations, mental retardation, loss of pain and vibratory senses, incoordination of movements, diarrhea, esophageal reflux, gastrointestinal paresis, facial abnormalities, altered dentition, increased salivary secretion, abnormalities of the sweat glands, bowel distension, fecal impaction, prolonged QT intervals (>440) a hallmark of sudden death, and orthostatic syncope, and blood pressure problems.